Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
The second episode of our ‘Enabling Successful Sites’ series features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Xoli Belgrave (Sr. Director, Head of Clinical Trial Diversity and Inclusion), Jamie Langley (Executive Director, Parexel Academy) and Dr. Lovie Negrin, CEO and Founder of Randomize now on how we can empower and leverage sites with the tools and training they need to more successfully recruit diverse patient populations for their studies. They talk about the impact of not including diverse patient populations in studies is discussed, the need for sponsors and CROs to share their diversity, equity, and inclusion strategies with investigator sites, and soft skills site staff need to have for necessary conversations.
Episode 1: Site feasibility and study start-up challenges
Episode 3: Taking the complexity out of oncology clinical trials
Episode 4: Partnering with sites to improve patient recruitment and retention
Episode 5: Strategies for improving communication between sites, sponsors and CROs
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Article
Making rare disease drug development personal
Jan 8, 2021
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Article
Making rare disease drug development personal
Jan 8, 2021
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025